Literature DB >> 20869081

Leucocyte depletion improves renal function in porcine kidney hemoreperfusion through reduction of myeloperoxidase+ cells, caspase-3, IL-1β, and tubular apoptosis.

Bin Yang1, Sarah A Hosgood, Simon J F Harper, Michael L Nicholson.   

Abstract

BACKGROUND: Leucocytes play crucial roles in ischemia reperfusion injury that is inevitable in kidney transplantation. Leucocyte-depleted hemoreperfusion improved post-ischemic renal function was demonstrated in our previous study and its underlying mechanisms were further investigated in this study.
METHODS: Porcine kidneys were subjected to 7 min warm ischemia and 2 h cold storage, and preserved by hemoreperfusion with or without leucocyte depletion for 6 h on an isolated organ perfusion system.
RESULTS: Tubulointerstitial damage was improved by leucocyte depletion, which was accompanied by reduced myeloperoxidase+ cell infiltration up to 91%. Apoptotic cells in tubular and interstitial areas were increased by hemoreperfusion, but tubular apoptosis was decreased by leucocyte depletion. The raised caspase-3 activity by hemoreperfusion was almost completely abolished by leucocyte depletion. In addition, the expression of IL-1β active subunit was enhanced by hemoreperfusion, but partially reduced by leucocyte depletion, although IL-1β precursor and HSP70 were increased by hemoreperfusion regardless of leucocyte depletion. Furthermore, myeloperoxidase+ cells were associated with caspase-3 activity, both of which were positively correlated with tubular apoptosis, IL-1β active subunit, tubulointerstitial damage, and serum creatinine, while HSP70 was linked to renal blood flow.
CONCLUSIONS: Leucocyte depletion improved post-ischemic renal function and structure was mainly due to reduced infiltration of myeloperoxidase+ cells, which was associated with decreased apoptosis, caspase-3 activity and IL-1β activation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869081     DOI: 10.1016/j.jss.2010.07.044

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  The role of innate immunity in donor organ procurement.

Authors:  Dianne B McKay
Journal:  Semin Immunopathol       Date:  2011-03-23       Impact factor: 9.623

2.  Kidney Normothermic Machine Perfusion Can Be Used as a Preservation Technique and a Model of Reperfusion to Deliver Novel Therapies and Assess Inflammation and Immune Activation.

Authors:  Azita Mellati; Letizia Lo Faro; Richard Dumbill; Pommelien Meertens; Kaithlyn Rozenberg; Sadr Shaheed; Corinna Snashall; Hannah McGivern; Rutger Ploeg; James Hunter
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

3.  Effects of Platelet-Rich Plasma (PRP) on a Model of Renal Ischemia-Reperfusion in Rats.

Authors:  Oriol Martín-Solé; Joan Rodó; Lluís García-Aparicio; Josep Blanch; Victoria Cusí; Asteria Albert
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

4.  Comparative Analysis of Risk Factors in Declined Kidneys from Donation after Brain Death and Circulatory Death.

Authors:  Zinah Zwaini; Meeta Patel; Cordula Stover; John Dormer; Michael L Nicholson; Sarah A Hosgood; Bin Yang
Journal:  Medicina (Kaunas)       Date:  2020-06-26       Impact factor: 2.430

Review 5.  Ex-vivo Kidney Machine Perfusion: Therapeutic Potential.

Authors:  Ruta Zulpaite; Povilas Miknevicius; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Front Med (Lausanne)       Date:  2021-12-24

6.  Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats.

Authors:  Carla Ferreyra; Félix Vargas; Isabel Rodríguez-Gómez; Rocío Pérez-Abud; Francisco O'Valle; Antonio Osuna
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

Review 7.  Large animal models for translational research in acute kidney injury.

Authors:  Balamurugan Packialakshmi; Ian J Stewart; David M Burmeister; Kevin K Chung; Xiaoming Zhou
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.